Edition:
United Kingdom

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

5.48USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
124,514
52-wk High
$16.70
52-wk Low
$4.99

About

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $136.71
Shares Outstanding(Mil.): 18.60
Dividend: --
Yield (%): --

Financials

  ALDX.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.47 -- --
ROI: -72.27 8.96 14.49
ROE: -75.02 10.09 15.79

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Aldeyra's eye drug meets main goal in late-stage study, shares surge

March 26 Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Earnings vs. Estimates